RAFAEL HOLDINGS, INC. Deferred Tax Liabilities, Net
RAFAEL HOLDINGS, INC. (RFL) had Deferred Tax Liabilities, Net of $138.00 thousand as of 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2025-10-29
- 2025-07-31: Deferred Tax Liabilities, Net $138.00K.
- 2025-04-30: Deferred Tax Liabilities, Net $9.00M.
- 2024-04-30: Deferred Tax Liabilities, Net $545.00K.
- 2024-01-31: Deferred Tax Liabilities, Net $545.00K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2025-07-31 | $138.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $9.00M 10-Q · filed 2025-06-11 |
| 2024-04-30 | $545.00K 10-Q · filed 2024-06-14 |
| 2024-01-31 | $545.00K 10-Q · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |